Loss Of Exclusivity Product Launches To Fuel Aurobindo’s FY26 Europe Growth

FY28 Inflection Point For Biosimilars

 
• By Vibha Ravi

Aurobindo is banking on launches of loss of exclusivity products and biosimilars to fuel sales in Europe as it awaits a US announcement on tariffs and predicts high single-digit growth overall during FY26 for now

Europe Seems Like A Lighthouse In The Rough Seas Of Business Uncertainty
Aurobindo Sees Safety On Europe's Shores Amid Fog In The US (Shutterstock)

More from Earnings

More from Products